2026 Media Partners

Take a look at the media partners who decided to support the 8th Targeted Radiopharmaceuticals Europe Summit. If you are interested in a media partnership, please contact info@hansonwade.com.

NuclioNews
Nuclio Media

Nuclio News is a dedicated digital media platform covering the latest developments across nuclear medicine, molecular imaging, radiopharmaceuticals and theranostics. Providing timely industry news, expert insights, research updates and market developments, the platform serves as a key information resource for scientists, clinicians, drug developers, manufacturers and investors operating within the radiopharmaceutical ecosystem. Through its coverage of emerging technologies, clinical advances and commercial activity, Nuclio News helps keep the global nuclear medicine community informed on the innovations shaping the future of precision oncology and targeted radiopharmaceutical therapies.

Learn more: Nuclionews.com/

 

Conference Image
Explore the Agenda

Discover the scientific, clinical and commercial strategies that will become your blueprint for accelerating targeted radiopharmaceuticals from discovery to patients.

Conference Image
Partner With Us

Showcase your technologies and services to 200+ senior decision-makers actively seeking CROs, CDMOs, isotope suppliers, radiopharmacies, dosimetry providers and specialist partners to advance the next generation of radiopharmaceuticals.

Conference Image
Join Europe's TRP Leaders:

Be part of Europe's most comprehensive targeted radiopharmaceuticals forum, uniting pharma, biotech, regulators, clinical centres, investors and solution providers to shape the future of radioligand therapy.